Quest diagnostics launches monkeypox virus testing

Company to be able to perform approximately 30,000 tests a week by the end of july, supplementing public health response physicians can order the novel quest diagnostics lab test beginning today and the cdc orthopoxvirus test the first half of august secaucus, n.j. , july 13, 2022 /prnewswire/ -- quest diagnostics (nyse: dgx), the world's leading provider of diagnostic information services, today announced the nationwide availability* of the company's lab-developed molecular diagnostic test to aid in the diagnosis of infection with the monkeypox virus, with plans to launch the cdc's orthopoxvirus test in the first half of august.
DGX Ratings Summary
DGX Quant Ranking